SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cephalon (CEPH) Coiled & Ready -- Ignore unavailable to you. Want to Upgrade?

To: christopher franck who wrote (4)12/22/1997 3:59:00 PM
From: Apple Jacks  Respond to of 10
 
Hey Christopher,

Sorry it took so long to reply but I was on holiday last week. I usually follow Cephalon on the other thread (although that has been very quiet of late).

I am still bullish on this stock (I am also being very patient). I expect Myotrophin approval by May or June and hopefully some news on Provigil will come out soon as well.

I will probably pick up some more calls for May or June, but will wait just a little longer.

Good Luck,

AJ



To: christopher franck who wrote (4)2/20/1998 4:08:00 PM
From: Apple Jacks  Read Replies (1) | Respond to of 10
 
I get the Neuroinvestment letter and the fellow that writes it (he contributes frequently to SI discussions) is quite bullish on Cephalon. He has a target price of $35 for year end! I am keeping a close eye on it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News